Aranesp (darbepoetin alfa), one of several erythropoiesis-stimulating agents, contracted, falling to $3.1 billion from $3.6 billion in 2007. Amgen attributed the flagging sales in part to a ...
Four Amgen products will be the sector's leaders: its arthritis drug etanercept (Enbrel), pegfilgrastim (Neulasta), darbepoetin alfa (Aranesp) and Epogen. More specifically, Enbrel will be the ...
Dharam J. Kumbhani, M.D., S.M.; Deepak L. Bhatt, M.D., F.A.C.C.; Anthony A. Bavry, M.D., M.P.H., F.A.C.C. Hypothesis: ESAs would be associated with a lower risk of ...
I mean it's a national outrage that we spend more money on drugs like Aranesp and Procrit that up your red blood count. It's never saved a person's life. We spend more money on these anti-medics ...
Amgen’s focus on blood cell medications continued in the 2000s, with the approval of Aranesp for the treatment of anaemic patients with chronic renal failure, and the 2002 approval of Neulasta ...